BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34135073)

  • 1. Impact of a tiered discharge opioid algorithm on prescriptions and patient-reported outcomes after open gynecologic surgery.
    Huepenbecker S; Hillman RT; Iniesta MD; Chen T; Cain K; Mena G; Lasala J; Wang XS; Williams L; Taylor JS; Lu KH; Ramirez PT; Meyer LA
    Int J Gynecol Cancer; 2021 Jul; 31(7):1052-1060. PubMed ID: 34135073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal patient-reported outcomes and restrictive opioid prescribing after minimally invasive gynecologic surgery.
    Hillman RT; Iniesta MD; Shi Q; Suki T; Chen T; Cain K; Williams L; Wang XS; Taylor JS; Mena G; Lasala J; Ramirez PT; Meyer LA
    Int J Gynecol Cancer; 2021 Jan; 31(1):114-121. PubMed ID: 33158876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an Enhanced Recovery After Surgery Program on Opioid Use and Patient-Reported Outcomes.
    Meyer LA; Lasala J; Iniesta MD; Nick AM; Munsell MF; Shi Q; Wang XS; Cain KE; Lu KH; Ramirez PT
    Obstet Gynecol; 2018 Aug; 132(2):281-290. PubMed ID: 29995737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and patient perspectives following implementation of tiered opioid prescription guidelines in gynecologic surgery.
    Glaser GE; Kalogera E; Kumar A; Yi J; Destephano C; Ubl D; Glasgow A; Habermann E; Dowdy SC
    Gynecol Oncol; 2020 May; 157(2):476-481. PubMed ID: 32107048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrarestrictive Opioid Prescription Protocol for Pain Management After Gynecologic and Abdominal Surgery.
    Mark J; Argentieri DM; Gutierrez CA; Morrell K; Eng K; Hutson AD; Mayor P; Szender JB; Starbuck K; Lynam S; Blum B; Akers S; Lele S; Paragh G; Odunsi K; de Leon-Casasola O; Frederick PJ; Zsiros E
    JAMA Netw Open; 2018 Dec; 1(8):e185452. PubMed ID: 30646274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal perioperative patient-reported outcomes in open compared with minimally invasive hysterectomy.
    Huepenbecker SP; Iniesta MD; Wang XS; Cain KE; Zorrilla-Vaca A; Shen SE; Basabe MS; Suki T; Garcia Lopez JE; Mena GE; Lasala JD; Williams LA; Ramirez PT; Meyer LA
    Am J Obstet Gynecol; 2024 Feb; 230(2):241.e1-241.e18. PubMed ID: 37827271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid-sparing anesthesia and patient-reported outcomes after open gynecologic surgery: a historical cohort study.
    Zorrilla-Vaca A; Ramirez PT; Iniesta-Donate M; Lasala JD; Wang XS; Williams LA; Meyer L; Mena GE
    Can J Anaesth; 2022 Dec; 69(12):1477-1492. PubMed ID: 36224506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained reduction of discharge opioid prescriptions in an enhanced recovery after thoracic surgery program: A multilevel generalized linear model.
    Zorrilla-Vaca A; Rice D; Brown JK; Antonoff M; Sepesi B; Hofstetter W; Swisher S; Walsh G; Vaporciyan A; Mehran R; Hagberg C; Mena GE
    Surgery; 2022 Feb; 171(2):504-510. PubMed ID: 34740455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative Opioid Use Using Enhanced Recovery After Surgery Guidelines for Benign Gynecologic Procedures.
    Movilla PR; Kokroko JA; Kotlyar AG; Rowen TS
    J Minim Invasive Gynecol; 2020 Feb; 27(2):510-517. PubMed ID: 31004796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in opioid use and postoperative pain scores after elective laparotomy with implementation of enhanced recovery after surgery protocol on a gynecologic oncology service.
    Schwartz AR; Lim S; Broadwater G; Cobb L; Valea F; Marosky Thacker J; Habib A; Havrilesky L
    Int J Gynecol Cancer; 2019 Jun; 29(5):935-943. PubMed ID: 31155518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Enhanced Recovery After Surgery and Opioid-Free Anesthesia on Opioid Prescriptions at Discharge From the Hospital: A Historical-Prospective Study.
    Brandal D; Keller MS; Lee C; Grogan T; Fujimoto Y; Gricourt Y; Yamada T; Rahman S; Hofer I; Kazanjian K; Sack J; Mahajan A; Lin A; Cannesson M
    Anesth Analg; 2017 Nov; 125(5):1784-1792. PubMed ID: 29049123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid prescribing practices during implementation of an enhanced recovery program at a tertiary care hospital.
    Gerrish AW; Fogel S; Lockhart ER; Nussbaum M; Adkins F
    Surgery; 2018 Oct; 164(4):674-679. PubMed ID: 30098812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Feasibility of Discharge Without an Opioid Prescription for Patients Undergoing Gynecologic Surgery.
    Margolis B; Andriani L; Baumann K; Hirsch AM; Pothuri B
    Obstet Gynecol; 2020 Dec; 136(6):1126-1134. PubMed ID: 33156191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bundle of opioid-sparing strategies (BOSS) to eliminate routine opioid prescribing in a urogynecology practice.
    Selle JM; Strozza DM; Branda ME; Gebhart JB; Trabuco EC; Occhino JA; Linder BJ; El Nashar SA; Madsen AM
    Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38801934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-operative opioid use in gynecologic oncology: a common comorbidity relevant to the peri-operative period.
    Ross ME; Wheeler LJ; Flink DM; Lefkowits C
    Int J Gynecol Cancer; 2019 Nov; 29(9):1411-1416. PubMed ID: 31473659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient characteristics and opioid use prior to discharge after open gynecologic surgery in an enhanced recovery after surgery (ERAS) program.
    Hillman RT; Sanchez-Migallon A; Meyer LA; Iniesta MD; Cain KE; Siverand AM; Veum SPL; Suki TS; Lasala JD; Ramirez PT
    Gynecol Oncol; 2019 Jun; 153(3):604-609. PubMed ID: 30902370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the impact of procedure-specific opioid prescribing recommendations on opioid stewardship following pelvic organ prolapse surgery.
    Linder BJ; Occhino JA; Wiest SR; Klingele CJ; Trabuco EC; Gebhart JB
    Am J Obstet Gynecol; 2019 Nov; 221(5):515.e1-515.e8. PubMed ID: 31226293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association between Implementation of an Enhanced Recovery after Cesarean Pathway with Standardized Discharge Prescriptions and Opioid Use and Pain Experience after Cesarean Delivery.
    McCoy JA; Gutman S; Hamm RF; Srinivas SK
    Am J Perinatol; 2021 Nov; 38(13):1341-1347. PubMed ID: 34282576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Success With Diminished Opioid Prescribing After Implementation of Standardized Postoperative Opioid Prescribing Guidelines: An Interrupted Time Series Analysis.
    Findlay BL; Britton CJ; Glasgow AE; Gettman MT; Tyson MD; Pak RW; Viers BR; Habermann EB; Ziegelmann MJ
    Mayo Clin Proc; 2021 May; 96(5):1135-1146. PubMed ID: 33958051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of a restrictive opioid prescription protocol after minimally invasive gynecologic oncology surgery.
    Kim SR; Laframboise S; Nelson G; McCluskey SA; Avery L; Kujbid N; Zia A; Bernardini MQ; Ferguson SE; May T; Hogen L; Cybulska P; Bouchard-Fortier G
    Int J Gynecol Cancer; 2021 Dec; 31(12):1584-1588. PubMed ID: 34750198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.